Logo image of DHCNI

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42 (DHCNI) Stock Fundamental Analysis

USA - NASDAQ:DHCNI - US25525P2065

17.15 USD
-0.16 (-0.9%)
Last: 10/10/2025, 9:21:34 PM
Fundamental Rating

2

Taking everything into account, DHCNI scores 2 out of 10 in our fundamental rating. DHCNI was compared to 130 industry peers in the Diversified REITs industry. The financial health of DHCNI is average, but there are quite some concerns on its profitability. DHCNI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

DHCNI had negative earnings in the past year.
In the past year DHCNI had a positive cash flow from operations.
DHCNI had negative earnings in 4 of the past 5 years.
In multiple years DHCNI reported negative operating cash flow during the last 5 years.
DHCNI Yearly Net Income VS EBIT VS OCF VS FCFDHCNI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

The Return On Assets of DHCNI (-6.03%) is worse than 83.85% of its industry peers.
DHCNI has a Return On Equity of -15.46%. This is in the lower half of the industry: DHCNI underperforms 78.46% of its industry peers.
Industry RankSector Rank
ROA -6.03%
ROE -15.46%
ROIC N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
DHCNI Yearly ROA, ROE, ROICDHCNI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

With a Gross Margin value of 17.80%, DHCNI is not doing good in the industry: 93.85% of the companies in the same industry are doing better.
DHCNI's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for DHCNI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
DHCNI Yearly Profit, Operating, Gross MarginsDHCNI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

4

2. Health

2.1 Basic Checks

DHCNI does not have a ROIC to compare to the WACC, probably because it is not profitable.
DHCNI has more shares outstanding than it did 1 year ago.
DHCNI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for DHCNI is higher compared to a year ago.
DHCNI Yearly Shares OutstandingDHCNI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
DHCNI Yearly Total Debt VS Total AssetsDHCNI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

DHCNI has an Altman-Z score of 0.36. This is a bad value and indicates that DHCNI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.36, DHCNI perfoms like the industry average, outperforming 41.54% of the companies in the same industry.
A Debt/Equity ratio of 1.42 is on the high side and indicates that DHCNI has dependencies on debt financing.
DHCNI has a Debt to Equity ratio of 1.42. This is comparable to the rest of the industry: DHCNI outperforms 43.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Altman-Z 0.36
ROIC/WACCN/A
WACC6.62%
DHCNI Yearly LT Debt VS Equity VS FCFDHCNI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

DHCNI has a Current Ratio of 3.37. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 3.37, DHCNI belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
DHCNI has a Quick Ratio of 3.37. This indicates that DHCNI is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of DHCNI (3.37) is better than 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 3.37
Quick Ratio 3.37
DHCNI Yearly Current Assets VS Current LiabilitesDHCNI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.64% over the past year.
Looking at the last year, DHCNI shows a small growth in Revenue. The Revenue has grown by 4.29% in the last year.
DHCNI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.53% yearly.
EPS 1Y (TTM)39.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.57%
Revenue 1Y (TTM)4.29%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%3.05%

3.2 Future

DHCNI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.46% yearly.
Based on estimates for the next years, DHCNI will show a small growth in Revenue. The Revenue will grow by 3.37% on average per year.
EPS Next Y20.16%
EPS Next 2Y17.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DHCNI Yearly Revenue VS EstimatesDHCNI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B
DHCNI Yearly EPS VS EstimatesDHCNI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

DHCNI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DHCNI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DHCNI Price Earnings VS Forward Price EarningsDHCNI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DHCNI indicates a rather expensive valuation: DHCNI more expensive than 93.85% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 27.86
DHCNI Per share dataDHCNI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

DHCNI's earnings are expected to grow with 17.46% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.46%
EPS Next 3YN/A

More info and screens

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.97%, DHCNI is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.00, DHCNI's dividend is way lower than its industry peers. On top of this 92.31% of the companies listed in the same industry pay a better dividend than DHCNI!
With a Dividend Yield of 0.97, DHCNI pays less dividend than the S&P500 average, which is at 2.43.
Industry RankSector Rank
Dividend Yield 0.97%

5.2 History

The dividend of DHCNI decreases each year by -45.60%.
DHCNI has been paying a dividend for over 5 years, so it has already some track record.
DHCNI has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-45.6%
Div Incr Years0
Div Non Decr Years3
DHCNI Yearly Dividends per shareDHCNI Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

DHCNI has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-3.36%
EPS Next 2Y17.46%
EPS Next 3YN/A
DHCNI Yearly Income VS Free CF VS DividendDHCNI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

More info and screens

DIVERSIFIED HEALTHCARE T - DHC 5 5/8 08/01/42

NASDAQ:DHCNI (10/10/2025, 9:21:34 PM)

17.15

-0.16 (-0.9%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners75.89%
Inst Owner ChangeN/A
Ins Owners0.48%
Ins Owner ChangeN/A
Market Cap4.14B
Analysts48
Price Target16.97 (-1.05%)
Short Float %0%
Short Ratio0.43
Dividend
Industry RankSector Rank
Dividend Yield 0.97%
Yearly Dividend0.04
Dividend Growth(5Y)-45.6%
DP-3.36%
Div Incr Years0
Div Non Decr Years3
Ex-Date07-15 2025-07-15 (0.3515625)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)25.74%
Min EPS beat(2)-71.02%
Max EPS beat(2)122.5%
EPS beat(4)2
Avg EPS beat(4)34.05%
Min EPS beat(4)-71.02%
Max EPS beat(4)122.5%
EPS beat(8)3
Avg EPS beat(8)16.12%
EPS beat(12)4
Avg EPS beat(12)5.38%
EPS beat(16)4
Avg EPS beat(16)-11.59%
Revenue beat(2)0
Avg Revenue beat(2)-0.26%
Min Revenue beat(2)-0.49%
Max Revenue beat(2)-0.04%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-2.43%
Max Revenue beat(4)1.32%
Revenue beat(8)2
Avg Revenue beat(8)-0.47%
Revenue beat(12)4
Avg Revenue beat(12)-0.38%
Revenue beat(16)4
Avg Revenue beat(16)-1.01%
PT rev (1m)-6.98%
PT rev (3m)2.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5%
EPS NY rev (1m)-12.16%
EPS NY rev (3m)-28.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.54%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.72
P/FCF N/A
P/OCF 46.46
P/B 2.23
P/tB 2.23
EV/EBITDA 27.86
EPS(TTM)-0.67
EYN/A
EPS(NY)-0.65
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)0.37
OCFY2.15%
SpS6.31
BVpS7.68
TBVpS7.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.03%
ROE -15.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.8%
FCFM N/A
ROA(3y)-4.29%
ROA(5y)-2.48%
ROE(3y)-10.69%
ROE(5y)-6.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.33%
GM growth 5Y-20.05%
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 1.42
Debt/FCF N/A
Debt/EBITDA 11.07
Cap/Depr 66.82%
Cap/Sales 12.33%
Interest Coverage N/A
Cash Conversion 37.41%
Profit Quality N/A
Current Ratio 3.37
Quick Ratio 3.37
Altman-Z 0.36
F-Score6
WACC6.62%
ROIC/WACCN/A
Cap/Depr(3y)103.34%
Cap/Depr(5y)92.72%
Cap/Sales(3y)19.78%
Cap/Sales(5y)17.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8.57%
EPS Next Y20.16%
EPS Next 2Y17.46%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.29%
Revenue growth 3Y2.63%
Revenue growth 5Y7.53%
Sales Q2Q%3.05%
Revenue Next Year3.66%
Revenue Next 2Y3.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y38.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year377.31%
EBIT Next 3Y72.02%
EBIT Next 5YN/A
FCF growth 1Y71.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y283.65%
OCF growth 3YN/A
OCF growth 5Y-15.84%